Abstract
Implantable cardiac monitors (ICMs) have excellent sensitivity for atrial fibrillation (AF) detection, ranging between 94-99%, but have a high number of false-positive (FP) detections. The Confirm Rx™ (Abbott, Chicago, IL, USA) with SharpSense™ (C-Rx) technology added a P-wave discriminator to its algorithm with the aim of reducing FP episodes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
